ClinicalTrials.gg
Not yet recruitingNCT06530901Updated Aug 5, 2024

Ultrasound of the Inferior Vena Cava in the Prevention of Hypotension After Induction of General Anesthesia

An observational study in Elderly Patients Undergoing Elective Non-cardiac Surgery, sponsored by Zhuan Zhang. Not yet recruiting at 1 site in China. Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-08-05.

Sponsored by Zhuan Zhang · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
65 Years to 85 Years
Sex
All
01

Study summary

Based on the preoperative ultrasound detection of various parametric indicators of the inferior vena cava cross-section, including the ratio of the inferior vena cava's long and short axes, cross-sectional area and circumference during two-dimensional and three-dimensional imaging, as well as the changes in respiratory variability of each parameter, we explored the predictive value of IVC ultrasound indicator parameters on hypotension after induction of general anesthesia in elderly patients undergoing elective non-cardiac surgery, screened the sensitive indicators, and calculated the cut-off values.

02

Conditions studied

  • Elderly Patients Undergoing Elective Non-cardiac Surgery

Browse trials for

Keywords

  • hypotension
  • general anesthesia
  • inferior vena cava
03

In context

Hypotension

885 studies on the registry are indexed under Hypotension; 195 are open to participants now.

This study's planned enrollment of 100 is above the median of 90 across 265 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Zhuan Zhang is the lead sponsor of 16 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Elderly patients undergoing elective non-cardiac surgery under general anesthesia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Elderly patients undergoing elective non-cardiac surgery under general anesthesia;
  • Age 65-85 years old;
  • (BMI) 18-28 kg/m2;
  • (ASA) class I-III.

Exclusion criteria

Exclusion Criteria:

  • Patient refusal or lack of cooperation;
  • Inability to communicate properly;
  • Severe sinus bradycardia, pacemaker implantation, atrioventricular block, and atrial fibrillation;
  • Presence of severe hepatic and renal function abnormalities;
  • Preoperative cardiac ultrasound suggesting \<50%;
  • Tricuspid valve displacement \<16 mm by preoperative cardiac ultrasound;
  • ;
  • Pulmonary hypertension;
  • Administration of drugs that inhibit the renin-angiotensin-aldosterone system;
  • Possibility of a difficult airway.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Elderly patients undergoing elective noncardiac surgery under general anesthesia

    Diagnostic Test: Multidimensional ultrasound of the inferior vena cava

Interventions

  • Diagnostic testMultidimensional ultrasound of the inferior vena cava

    Cross-sectional parameters of the inferior vena cava include two-dimensional longitudinal diameter, cross-sectional length and short diameter, circumference, and cross-sectional area, as well as cross-sectional length and short diameter, circumference, and cross-sectional area in three-dimensional imaging

06

What researchers measure

Primary outcomes

  1. Changes in the level of Mean Arterial Pressure

    The outcome above should be measured at the time before induction, 1 min after induction, 2 min after induction, 3 min after induction, 4 min after induction, 5 min after induction,10 min after induction

    Time frame: Baseline (before induction), 10 min after induction

  2. Changes in the level of Systolic Blood Pressure

    The outcome above should be measured at the time before induction, 1 min after induction, 2 min after induction, 3 min after induction, 4 min after induction, 5 min after induction,10 min after induction

    Time frame: Baseline (before induction), 10 min after induction

  3. Multidimensional ultrasound of the inferior vena cava

    The outcome above should be measured at the time before induction

    Time frame: Baseline (before induction)

Secondary outcomes

  1. Changes in the level of Heart Rate

    The outcome above should be measured at the time before induction, 1 min after induction, 2 min after induction, 3 min after induction, 4 min after induction, 5 min after induction,10 min after induction

    Time frame: Baseline (before induction), 10 min after induction

  2. Changes in the level of Diastolic Blood Pressure

    The outcome above should be measured at the time before induction, 1 min after induction, 2 min after induction, 3 min after induction, 4 min after induction, 5 min after induction,10 min after induction

    Time frame: Baseline (before induction), 10 min after induction

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2024; primary completion for Mar 2025, 6 months later.

Of 146 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 6 months is below that.

Counting every sponsor, half of 151 studies reached it within 11 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 28, 2024
First posted
Jul 31, 2024
StartEst.
Sep 1, 2024
Primary completionEst.
Mar 31, 2025
CompletionEst.
Mar 31, 2025
Last update
Aug 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06530901
Lead sponsor
Zhuan Zhang
Responsible party
Zhuan Zhang (Doctor, Yangzhou University) — Sponsor-investigator
First posted
Jul 31, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Mar 31, 2025 (estimated)
Completion
Mar 31, 2025 (estimated)
Last update
Aug 5, 2024

Study contacts

zhuan zhang, professor
Contact
zhangzhuancg@163.com
+8615062791355
zhuan zhang, professor
principal investigator · The Affiliated Hospital of Yangzhou University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion